Lv1
40 积分 2024-07-31 加入
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
7天前
已完结
What makes placebo-controlled trials unethical?
14天前
已完结
Questioning the methodologic superiority of 'placebo' over 'active' controlled trials
14天前
已完结
Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial
18天前
已完结
基于加速康复外科理念的疼痛护理管理模式在肠癌围术期中的应用效果
22天前
已关闭
Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus Immunotherapy and targeted therapy in HCC
25天前
已完结
术前预后营养指数、炎症标志物与结直肠癌患者预后及术后并发症的关系研究
28天前
已关闭
Comparison of early mobilization and diet rehabilitation program with conventional care after laparoscopic colon surgery: a prospective randomized controlled trial
29天前
已完结
Combined Mechanical and Oral Antibiotic Bowel Preparation Reduces Incisional Surgical Site Infection and Anastomotic Leak Rates After Elective Colorectal Resection: An Analysis of Colectomy-Targeted ACS NSQIP
1个月前
已完结
皖公网安备34019202002308
